Shopping Cart 0
Cart Subtotal
USD 0

Aradigm Corp (ARDM) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Aradigm Corp (ARDM)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aradigm Corp (Aradigm) is a specialty pharmaceutical company that develops and commercializes inhalation drugs for the prevention and treatment of severe respiratory diseases. The company's product pipeline includes Pulmaquin (ARD-3150) and Lipoquin (ARD-3100) for the treatment of non-cystic bronchiectasis (BE) and cystic fibrosis (CF); ARD-1100, liposomal ciprofloxacin for the treatment of inhalation tularemia, anthrax infections, Q fever and pneumonic plague and ARD-1600, for the prevention and treatment of respiratory and other diseases in tobacco smokers through smoking cessation. Its proprietary pulmonary drug delivery platform, AERx, is customized for the delivery of drugs to the target along with liposomal formulations. Aradigm is headquartered in Hayward, California, the US.

Aradigm Corp Key Recent Developments

Mar 23,2018: Aradigm Reports Fourth Quarter 2017 And Full Year Financial Results

Feb 09,2018: Aradigm Announces Personnel Changes

Nov 02,2017: Aradigm Announces Third Quarter 2017 Financial Results

Oct 10,2017: Aradigm Regains Compliance with NASDAQ Listing Requirements

Aug 10,2017: Aradigm Announces Second Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Aradigm Corp-Key Facts 5

Aradigm Corp-Key Employees 6

Aradigm Corp-Key Employee Biographies 7

Aradigm Corp-Major Products and Services 8

Aradigm Corp-History 9

Aradigm Corp-Company Statement 11

Aradigm Corp-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Company Overview 14

Aradigm Corp-Business Description 15

Aradigm Corp-Corporate Strategy 16

Aradigm Corp-SWOT Analysis 17

SWOT Analysis-Overview 17

Aradigm Corp-Strengths 17

Aradigm Corp-Weaknesses 18

Aradigm Corp-Opportunities 19

Aradigm Corp-Threats 20

Aradigm Corp-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Aradigm Corp, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

Feb 09, 2018: Aradigm Announces Personnel Changes 31

Nov 02, 2017: Aradigm Announces Third Quarter 2017 Financial Results 32

Oct 10, 2017: Aradigm Regains Compliance with NASDAQ Listing Requirements 33

Aug 10, 2017: Aradigm Announces Second Quarter 2017 Financial Results 34

May 15, 2017: Aradigm Announces First Quarter 2017 Financial Results 35

Mar 28, 2017: Aradigm Announces Fourth Quarter 2016 and Full Year Financial Results 36

Section 6-Appendix 37

Methodology 37

Ratio Definitions 37

About GlobalData 41

Contact Us 41

Disclaimer 41


List Of Figure

List of Figures

Aradigm Corp, Performance Chart (2013-2017) 25

Aradigm Corp, Ratio Charts 27

Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Aradigm Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29


List Of Table

List of Tables

Aradigm Corp, Key Facts 5

Aradigm Corp, Key Employees 6

Aradigm Corp, Key Employee Biographies 7

Aradigm Corp, Major Products and Services 8

Aradigm Corp, History 9

Aradigm Corp, Subsidiaries 13

Aradigm Corp, Key Competitors 21

Aradigm Corp, Ratios based on current share price 22

Aradigm Corp, Annual Ratios 23

Aradigm Corp, Annual Ratios (Cont...1) 24

Aradigm Corp, Interim Ratios 26

Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Aradigm Corp, Recent Deals Summary 30

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 40

Efficiency Ratios 40

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Aradigm Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Novartis AG

Gilead Sciences Inc

Axentis Pharma AG

Aptalis Pharma US Inc

Alexza Pharmaceuticals Inc